Clinical TrialID 7693

Danlou Tablets to Prevent Left Ventricular Remodeling

NCT02675322

Left Ventricular Remodeling|Acute Myocardial Infarction

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Formula: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7693
Evidence Id
7693
Core Evidence Id
7693
Source Clinical Trial Id
7691
Herb2 Clinical Trial Id
HBCT007691
Nct Id
NCT02675322
Title
Danlou Tablets to Prevent Left Ventricular Remodeling
Status
Completed
Phase
Phase 4
Study Result
No
Study Condition
Left Ventricular Remodeling|Acute Myocardial Infarction
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Danlou Tablets|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
82
Outcome Measure
change in the Left Ventricular End Diastolic Volume Index from baseline to 90 days, Left Ventricular End Diastolic Volume Index (LVEDVi) measured by two-dimensional echocardiography., 90 days
Sponsor Collaborator
shuai Mao
Funded By
OTHER
Location
Other Id
GuangdongPHTCM
Start Date
2012-01
Primary Completion Date
2015-01
Completion Date
2015-12
First Posted
2016-02-05
Results First Posted
Last Update Posted
2016-02-05
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02675322
Title Cn
Title En
Danlou Tablets to Prevent Left Ventricular Remodeling
Bilingual Status
semi_complete